Results 151 to 160 of about 1,071,501 (260)
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participants. [PDF]
Thompson AJ +27 more
europepmc +1 more source
Abstract Background and Objectives Viral load (VL) quantification for human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) is essential for clinical monitoring, treatment response assessment and post‐donation interpretation.
Adriaan Meyer, Suné Saayman
wiley +1 more source
Serum HBV RNA: a promising biomarker for blood product safety screening and enhanced diagnostic efficiency in chronic hepatitis B virus infection. [PDF]
Yu S, Guo Y, Zhang C.
europepmc +1 more source
Background Patients with schizophrenia experience gaps in the human immunodeficiency virus (HIV) care continuum. We examined the impact of dual enrollment in Medicare upon HIV testing and retention among Medicaid‐enrolled patients with schizophrenia.
Karly Murphy +13 more
wiley +1 more source
Sequencing of serum hepatitis B virus (HBV) RNA as a novel method for the genome analysis of HBV
The genome of hepatitis B virus (HBV) can be assessed by sequence analysis of HBV DNA in serum. In most chronic HBV infected patients treated with potent nucleos(t)ide analogues (NAs) this approach however is limited by the fast decrease of serum HBV DNA during NA treatment.
openaire +2 more sources
ANP32A and ANP32B bridge HBV RNA-ELAVL1-CRM1 and mediate HBV RNAs nuclear export.
(A-D) HepG2-NTCP cells were transfected with ANP32A or ANP32B targeted siRNA. The cells were infected with HBV at an MOI = 200 and were maintained with DMEM medium supplemented with 2.5% DMSO for 5 days.
Chuanjian Wu (15877596) +16 more
core +1 more source
ABSTRACT People with HIV (PWH) are living longer, but contemporary data on non–AIDS‐defining cancers (NADCs) in Italy remain limited. We assessed incident cancers in a retrospective cohort of PWH in Milan, Italy, between January 2000 and December 2023. Follow‐up was grouped into 2000–2007, 2008–2015, and 2016–2023. Incidence rates (IRs) were calculated
Giacomo Pozza +14 more
wiley +1 more source
Stem cell platforms offer distinct therapeutic, supportive and research‐enabling applications in oncology. Haematopoietic stem cell transplantation is established for selected haematological malignancies. Engineered MSCs, NSCs and pluripotent stem cell‐derived products remain investigational anticancer platforms.
Ruba Altahla +5 more
wiley +1 more source
ABSTRACT Aim Metabolic syndrome (MetS) is a known risk factor for hepatocellular carcinoma (HCC), but the impact of cumulative MetS burden and changes in MetS status over time remains unclear. This study aimed to assess these associations using a large‐scale Japanese health dataset.
Yutaka Yata +9 more
wiley +1 more source
Synergistic Regulation of Biomaterials and Macrophages: A Novel Paradigm in Immunotherapy
Bioengineered materials mediating the modulation of macrophage plasticity and inflammatory signals in the tumor microenvironment effectively remodel immunoregulatory states, boost antitumor immunity, and promote tissue repair, achieving synergistic therapeutic outcomes.
Jiayu Zhang +16 more
wiley +1 more source

